NCT06227572 (CATNAP) is a NA clinical trial of CATNAP MI in Obstructive Sleep Apnea, sponsored by Washington State University.

Who is sponsoring NCT06227572?

NCT06227572 is sponsored by Washington State University.

What drugs are being tested in NCT06227572?

Interventions in NCT06227572: CATNAP MI.

What condition does NCT06227572 study?

NCT06227572 studies Obstructive Sleep Apnea, Cognitive Change.

Is NCT06227572 still recruiting?

NCT06227572 is currently recruiting now. Last updated 9 January 2026.

Last reviewed 2026-01-09 · How we verify

NCT06227572: CATNAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognition After OSA Treatment Among Native American People (CATNAP)

Recruiting now NA Last updated 9 January 2026

What this trial tests

NA trial testing CATNAP MI in Obstructive Sleep Apnea in 140 participants. Currently enrolling.

Timeline

6 February 2025

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Washington State University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	140
Start date	6 February 2025
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across United States

Drugs / interventions tested

CATNAP MI

Conditions studied

Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
Cognitive Change — all drugs for Cognitive Change →

Sponsor

Washington State University

Who can join

40 and older, any sex, with Obstructive Sleep Apnea or Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting

Other Washington State University trials

Trials by the same sponsor.

NCT07088237 — Testing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery (CalmiFy II) · NA · not yet recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07171359 — TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) · NA · not yet recruiting
NCT07052318 — Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery · recruiting
NCT06804239 — Improving Activity in Adults With Chronic Pain With Online Resources · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06227572 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington State University
Last refreshed: 9 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06227572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing